EUVIMEDEUVIMED entdecken
CrossrefInfokarte

The Superficial Femoral-Popliteal Vein Graft: A Reliable Conduit for Large-Caliber Arterial and Venous Reconstructions

Scott A. Seidel, J. Gregory Modrall, Mark R. Jackson, R. James Valentine, G. Patrick Clagett

Perspectives in Vascular Surgery · 2001-01-01 · 14 (01) · 0057-0080

DOI: 10.1055/s-2001-13849 ↗
AbstractBibliografische Angaben

Abstract

ABSTRACT -Vascular surgeons are increasingly called upon to perform arterial reconstructions in patients who have unusable or absent saphenous veins forcing consideration of alternative conduits. Although prosthetic grafts have excellent performance when used as bypasses involving the aorta and its branches, there are clearly circumstances in which autogenous conduits are preferable. The superficial femoral popliteal vein (SFPV) has proven to be an outstanding alternative in these situations. Although the SFPV was originally used at our institution for the treatment of aortic graft infections, the success of reconstructions for this indication has led us to utilize the SFPV conduit in many other situations. The SFPV has proven to be superior to prosthetic grafts for infrainguinal limb salvage procedures and for hemodialysis access in certain situations. In addition, the SFPV appears to be the conduit of choice for use in infected fields of all types and for large caliber venous reconstructions. The purpose of this article is to review the use of the SFPV conduit in creation of the neoaortoiliac system (NAIS), update our results, and survey alternative uses for this versatile conduit. We also address the technical details of its harvest and implantation technique.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →